Dr. Mukul Gupta, MD
Claim this profileSansum Clinic
Studies Breast Cancer
Studies Adenocarcinoma
6 reported clinical trials
15 drugs studied
Area of expertise
1Breast Cancer
HER2
Stage IV
lymph node
2Adenocarcinoma
Stage III
Affiliated Hospitals
Clinical Trials Mukul Gupta, MD is currently running
ARX788
for HER2-Positive Breast Cancer
This trial tests ARX788, a new IV medicine, for patients with HER2-positive metastatic breast cancer who did not respond well to T-DXd. The medicine targets a specific protein on cancer cells to help stop their growth.
Recruiting1 award Phase 28 criteria
RGX-202-01 Combination Therapy
for Colorectal Cancer
This is a Phase 1 study currently evaluating PO administered ompenaclid in combination with FOLFIRI and bevacizumab in patients with advanced (i.e., locally advanced and unresectable, or metastatic) previously treated colorectal adenocarcinoma. The single agent ompenaclid dose escalation stage and the ompenaclid in combination with FOLFIRI and bevacizumab dose escalation stage of the study has been completed; the expansion stage of ompenaclid in combination with FOLFIRI and bevacizumab is ongoing. In April-24 a protocol amendment added a new dose escalation and expansion stage which will evaluate ompenaclid in combination with FOLFOX and bevacizumab in patients with metastatic CRC. It is anticipated that a total of 30 patients will be enrolled in this new dose escalation and expansion stage of the study.
Recruiting1 award Phase 1
More about Mukul Gupta, MD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mukul Gupta, MD has experience with
- Canakinumab
- Placebo
- Abemaciclib
- NovoTTF-100L(P)
- NovoTTF-200T
- Nab Paclitaxel
Breakdown of trials Mukul Gupta, MD has run
Adenocarcinoma
Stomach Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mukul Gupta, MD specialize in?
Mukul Gupta, MD focuses on Breast Cancer and Adenocarcinoma. In particular, much of their work with Breast Cancer has involved HER2 patients, or patients who are Stage IV.
Is Mukul Gupta, MD currently recruiting for clinical trials?
Yes, Mukul Gupta, MD is currently recruiting for 2 clinical trials in Santa Barbara California. If you're interested in participating, you should apply.
Are there any treatments that Mukul Gupta, MD has studied deeply?
Yes, Mukul Gupta, MD has studied treatments such as Canakinumab, Placebo, Abemaciclib.
What is the best way to schedule an appointment with Mukul Gupta, MD?
Apply for one of the trials that Mukul Gupta, MD is conducting.
What is the office address of Mukul Gupta, MD?
The office of Mukul Gupta, MD is located at: Sansum Clinic, Santa Barbara, California 93105 United States. This is the address for their practice at the Sansum Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.